March 30, 2009Lilly's Experimental Schizophrenia Drug Fails Major TrialOver the weekend, news came out that Eli Lilly's compound LY2140023, also known as mGlu2/3, failed to outperform placebo in a major phase 2 clinical trial, marking a major setback for the drug. That's discouraging news for Lilly, as the drug had shown some promise in an earlier trial of about 200 patients and had gotten a ton of press attention as being a new way to address psychosis without larding the pounds onto patients. The drug works on glutamate receptors instead of the usual antipsychotic target of dopamine receptors. "In the latest trial, however, the results fell short of the mark. Lilly tested the drug on 393 patients for four weeks. The drug failed to outperform Zyprexa. More surprisingly, Lilly said the drug did not outperform a placebo. The response of patients to the placebo was approximately double that normally seen in schizophrenia clinical trials." It's interesting that there was such a large placebo response in the trial, especially since placebo response in trials involving patients with psychosis generally runs around a 10 percent to 20 percent response rate (at least in trials I'm familiar with). It's also interesting that placebo performed roughly as well as Zyprexa. In a press release, the company noted: "A higher-than-expected placebo response was observed (14.6 points improvement) as measured by the Positive and Negative Syndrome Scale (PANSS) total score. The primary analyses did not demonstrate that any of the four LY2140023 monohydrate doses (5, 20, 40 and 80 mg taken twice daily) separated from placebo. Similarly, olanzapine at 15mg once daily also did not separate from placebo." Lilly plans more clinical trials of LY2140023. Posted by Philip Dawdy at March 30, 2009 12:05 AM
del.icio.us
Digg it
reddit
Comments
Dear Shareholders, Don't panic. We will find a way to approve the drug in the next clinical trial. FDA is on our $ide. I think they need to fine tune the drug focusing on the glutamate receptors and consider all brains and bodies react differently. I also think comparing it to Zyprexa is what their problem is, but then Zyprexa is a problem drug already. Posted by: Stephany at March 30, 2009 08:32 AMAbout that big placebo effect: Maybe the subjects were told they were testing a new drug for schizophrenia symptoms that was NOT an atypical antipsychotic. Given the hell people have been through on the atypicals... that would have set off such a tidal wave of hope that EVERYONE in the study group would have started feeling better! Posted by: Johanna at March 30, 2009 11:38 AMhttp://www.alternativementalhealth.com/articles/causesofschizophrenia.htm Hurry, Lilly. Your Zyp. patent is running out in 2011. If this latest fails, just add a couple of molecules to Zyp., change the name and color of the capsule, go to the FDA and you're in business: Remember, that's what you did with Prozac! Posted by: Anon. at March 30, 2009 06:30 PMHey Stephany: Tom, calm down, I was ripping Zyprexa. Lilly is up against Merck on this glutamate SZ drug. ZYprexa should be off the market, so should Seroquel, want to talk real problems? All of these drugs kill people, or ruin them for life. Isn't THAT the real problem??? Posted by: Stephany at March 30, 2009 11:00 PMOh I think it's Wyeth. Posted by: Stephany at March 31, 2009 09:38 AMhttp://www.alternativementalhealth.com/articles/causesofschizophrenia.htm There are 29 known causes of schizophrenia. Correcting them can cure patients. According to the author of this site, "The term 'schizophrenia' is an inadequate and misleading diagnosis. 'Disperceptions of unknown cause' is a better term." He then goes on to list his 29 "causes of schizophrenia," which he just described as "disperceptions of unknown cause." So how is it that he knows the cause of these "disperceptions" since by his own definition they're of "unknown cause"? We don't know the cause of schizophrenia. We do know that many conditions and substances can induce psychosis, but psychosis doesn't automatically equate with schizophrenia. And Pfeiffer doesn't (didn't, actually -- he's been dead for more than 20 years) get to change the definition to better suit his argument. Interesting Pfeiffer trivia, from his obituary in The New York Times: "In 1977, it was revealed that Dr. Pfeiffer was one of several researchers who had performed experiments in behavior control for the Central Intelligence Agency. Between 1955 and 1964, he administered the drug LSD to prisoners in Atlanta and Bordentown, N.J., under a program financed indirectly by the C.I.A. " Posted by: lkhllywd at March 31, 2009 02:42 PMAbout lillys " failed trial" with LY2140023-- they plan to continue because of success in previous trials. It is very common to have an inconclusive test. Also, how strange placebo out performed Zyprexa- it is the best at targeting positive symptons. But the s/e are killers. " FURIOUS SEASONS" is the place to go to gloat/whine over drugs that could help the M.I. Just wonder, are any of you really sick? Posted by: LUCIE at April 2, 2009 12:32 PMThe CIA is a well-known infiltrator - and drug supplier. Post a comment
|
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog Alison Bass
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

